Mynaric AG header image

Mynaric AG

M0YN

Equity

ISIN DE000A31C305 / Valor 121337525

Xetra (2025-08-01)
EUR 0.17%

Mynaric AG
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Mynaric AG, a company publicly traded on both the Nasdaq and Frankfurt stock exchanges, specializes in the development and manufacturing of optical communications terminals for a variety of applications including terrestrial, mobility, airborne, and space-based platforms. Founded in 2009 and headquartered in Munich, Germany, with additional facilities in Los Angeles, California, and Washington, D.C., Mynaric aims to revolutionize data transmission through its laser communication networks. These networks are designed to enable ultra-high data rates and secure, long-distance data exchange between moving objects, enhancing connectivity across the globe. Over the years, Mynaric has achieved significant technological milestones, including setting world records for air-to-ground data transmission speeds in collaboration with notable partners such as Airbus/Cassidian and Facebook. The company's growth trajectory has been marked by its initial public offering on the Frankfurt stock exchange, followed by an IPO on Nasdaq, and the establishment of its first serial production facility, positioning Mynaric as a leader in the industrialization of laser communication systems.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (10.11.2025):

Mynaric AG’s FY 2023 financial results reveal a year of solid progress and increasing momentum. The company reported improvements in key performance indicators – most notably a strong increase in cash received from customer contracts and a robust optical communications terminal backlog – while setting the stage for operational milestones such as its first unit shipment in 1Q 2024. These results underscore the company’s growing market presence, deliberate focus on operational excellence, and a reinforced pipeline of customer opportunities as it looks ahead to FY 2024.

Revenue & Income Performance

For FY 2023, Mynaric AG achieved revenue figures around EUR 6.0 million, reflecting steady growth compared to prior periods. The financial measures, including non-IFRS metrics, indicate that the company is managing its income and cost structure effectively while investing in its production ramp-up.

Customer Contract Cash-In & Backlog

The report highlights a significant increase in cash-in from customer contracts – a key indicator of forthcoming revenue during product delivery phases. Additionally, a strong optical communications terminal backlog underscores sustained demand and beneficial market positioning.

Production Milestones & Future Outlook

Mynaric AG marked an important production milestone with the first unit shipment in 1Q 2024. The multiple awards recently received and the strongest customer pipeline in its history demonstrate the company’s solid foundation for growth and its targeted approach towards government constellation projects and serial production.

Financial Position & Operational Focus

The balance sheet figures reflect healthy cash and cash equivalents, managed inventories, and planned capital expenditure. Together with the push for operational excellence, these results position Mynaric AG well for both current performance improvements and future expansion as the company continues to execute its strategic plans.

Summarized from source with an LLMView Source

Key figures

-98.9%1Y
-99.5%3Y
-99.7%5Y

Performance

342%1Y
192%3Y
150%5Y

Volatility

Market cap

9 M

Market cap (USD)

Daily traded volume (Shares)

Daily traded volume (Shares)

1 day high/low

1.585 / 1.255

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
2.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.00
Leonardo Ceresa
Switzerland, 04 Mar 2025
star star star star star
Ich finde es ein gutes Anlageinstrument

EQUITIES OF THE SAME SECTOR

Vertex Inc
Vertex Inc Vertex Inc Valor: 55908112
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%USD 19.79
All for One Group SE
All for One Group SE All for One Group SE Valor: 192106
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.46%EUR 39.80
AIXTRON SE
AIXTRON SE AIXTRON SE Valor: 4566068
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.21%EUR 16.32
Procore Technologies Inc
Procore Technologies Inc Procore Technologies Inc Valor: 53026320
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.30%USD 71.09
Entegris Inc
Entegris Inc Entegris Inc Valor: 1102899
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.06%USD 73.66
Exact Sciences Corp
Exact Sciences Corp Exact Sciences Corp Valor: 1183218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%USD 100.90
Acuity Brands Inc
Acuity Brands Inc Acuity Brands Inc Valor: 1327728
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.26%USD 349.36
Lem Holding SA
Lem Holding SA Lem Holding SA Valor: 2242762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%CHF 303.00
Privia Health Group Inc
Privia Health Group Inc Privia Health Group Inc Valor: 111013233
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.28%USD 23.74
RxSight Inc
RxSight Inc RxSight Inc Valor: 112649019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
13.41%USD 10.15